Pacific Ethanol Inc. (NASDAQ:PEIX) gross profit (loss) improved significantly to a gross profit of $32.9 million for 2013 from a gross loss of $19.5 million for 2012. Pacific Ethanol Inc. (NASDAQ:PEIX) shares after opening at $15.95 moved to $16.61 on last trade day and at the end of the day closed at $15.58. Company price to sales ratio in past twelve months was calculated as 0.28 and price to cash ratio as 48.21. Pacific Ethanol Inc. (NASDAQ:PEIX) showed a negative weekly performance of -8.94%.
Moody’s Investors Service upgraded Endeavour International Corporation’s (NYSE:END) Corporate Family Rating (CFR) to Caa2 from Caa3, its first priority notes rating to Caa2 from Caa3, and its second priority notes to Caa3 from Ca. Endeavour’s Speculative Grade Liquidity rating was changed to SGL-3 from SGL-4 and the outlook was changed to stable from negative. Endeavour International Corporation (NYSE:END) shares fell -3.85% in last trading session and ended the day on $3.25. END return on equity ratio is recorded as -162.40% and its return on assets is -6.40%. Endeavour International Corporation (NYSE:END) yearly performance is 14.84%.
MEI Pharma, Inc. (NASDAQ:MEIP) just hit a fresh high moving above the psychologically-important $10 per share level for the first time. MEI Pharma Inc. (NASDAQ:MEIP) shares moved down -3.55% in last trading session and was closed at $11.13, while trading in range of $10.98 – $12.23. MEI Pharma Inc. (NASDAQ:MEIP) year to date (YTD) performance is 38.95%.
Identiv Group, Inc. (NASDAQ:INVE) yesterday announced that it has entered into a $20.0 million term loan and line-of-credit agreement through Opus Bank’s Technology Banking Division. The proceeds of the transaction will be used to retire existing debt and enhance liquidity, creating a stronger financial platform to accelerate growth. Identive Group, Inc. (NASDAQ:INVE) weekly performance is 24.18%. On last trading day company shares ended up $1.13. Identive Group, Inc. (NASDAQ:INVE) distance from 50-day simple moving average (SMA50) is 23.50%. Analysts mean target price for the company is $1.25.